We are live on ! Find out more
RIGL icon

Rigel Pharmaceuticals
RIGL

94 hedge funds and large institutions have $287M invested in Rigel Pharmaceuticals in 2013 Q2 according to their latest regulatory filings, with 94 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

86% less call options, than puts

Call options by funds: $399K | Put options by funds: $2.79M

Holders
94
Holders Change
+94
Holders Change %
–
% of All Funds
3.07%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.03%
New
94
Increased
–
Reduced
–
Closed
–
Calls
$399K
Puts
$2.79M
Net Calls
-$2.39M
Net Calls Change
-$2.39M

Top Buyers

No buyers this quarter

Top Sellers

No sellers this quarter
Name Holding Trade Value Shares
Change 		Change in
Stake
Fidelity Investments
1
Fidelity Investments
Massachusetts
$35.3M +$47.9M +1,056,287 New
BI
2
BVF Inc
California
$32.5M +$44.1M +973,070 New
Wellington Management Group
3
Wellington Management Group
Massachusetts
$30.6M +$41.4M +914,710 New
O
4
OppenheimerFunds
New York
$20M +$27.2M +600,000 New
T. Rowe Price Associates
5
T. Rowe Price Associates
Maryland
$16.6M +$22.5M +496,460 New
Vanguard Group
6
Vanguard Group
Pennsylvania
$15.2M +$20.7M +455,775 New
PAI
7
Palo Alto Investors
California
$13.1M +$17.8M +393,558 New
State Street
8
State Street
Massachusetts
$13M +$17.7M +390,068 New
BFA
9
BlackRock Fund Advisors
California
$12.9M +$17.5M +385,348 New
NMC
10
NEA Management Company
Maryland
$10.8M +$14.7M +324,315 New
BC
11
Broadfin Capital
New York
$10.2M +$13.8M +305,000 New
BIT
12
BlackRock Institutional Trust
California
$9.76M +$13.2M +292,211 New
DM
13
Deerfield Management
New York
$9.05M +$12.3M +271,005 New
Millennium Management
14
Millennium Management
New York
$6.02M +$8.17M +180,357 New
UBS AM
15
UBS AM
Illinois
$4.89M +$6.64M +146,560 New
Northern Trust
16
Northern Trust
Illinois
$4.07M +$5.53M +121,990 New
MG
17
Meditor Group
Bermuda
$3.01M +$4.08M +90,000 New
Dimensional Fund Advisors
18
Dimensional Fund Advisors
Texas
$2.86M +$3.88M +85,723 New
D.E. Shaw & Co
19
D.E. Shaw & Co
New York
$2.77M +$3.75M +82,844 New
TCM
20
Tekla Capital Management
Massachusetts
$2.76M +$3.75M +82,710 New
Norges Bank
21
Norges Bank
Norway
$2.3M +$3.12M +68,782 New
Deutsche Bank
22
Deutsche Bank
Germany
$2.18M +$2.96M +65,239 New
Balyasny Asset Management
23
Balyasny Asset Management
Illinois
$2M +$2.72M +59,971 New
TCIM
24
TIAA CREF Investment Management
New York
$1.69M +$2.3M +50,727 New
TC
25
TFS Capital
Pennsylvania
$1.58M +$2.15M +47,374 New
1
2 3 4

RIGL Hedge Fund Activity: Q2 2013 in Review

94 of the 3,064 institutional investors tracked by Wall St. Rank reported a position in Rigel Pharmaceuticals (RIGL) for Q2 2013, worth a combined $287M.

Buyers outnumbered sellers: 94 funds opened new RIGL positions and 0 closed out — a net gain of 94 holders — while 0 added to existing stakes and 0 trimmed.

  • 94 institutional investors held Rigel Pharmaceuticals (RIGL) as of Q2 2013, up from 0 in Q1 2013.
  • Funds reported $287M of Rigel Pharmaceuticals stock for Q2 2013.
  • 94 funds opened new Rigel Pharmaceuticals positions in Q2 2013 and 0 closed out, a net change of +94 holders.

Based on aggregated 13F filings for Q2 2013.